NexGard chewable tablets for dogs

NexGard is a prominent veterinary medication used to protect dogs against fleas and ticks. The brand was originally developed by Merial, a leading animal health company founded in France. In 2017, as part of a significant strategic asset swap, Boehringer Ingelheim acquired Merial, bringing NexGard under its extensive animal health portfolio.

Boehringer Ingelheim, a German family-owned pharmaceutical company, remains the ultimate owner of the brand. Manufacturing for NexGard occurs at high-tech facilities globally, with major production sites located in Brazil, France, and the United States to serve international markets. The product is widely distributed through veterinary clinics and authorized retailers worldwide.